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 expression critically 
inﬂuences T cell development and selection
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Sequential rearrangement of the T cell receptor for antigen (TCR) 
 
 
 
 and 
 
  
 
chains is a 
hallmark of thymocyte development. This temporal control is lost in TCR transgenics because 
the 
 
 
 
 chain is expressed prematurely at the CD4
 
 
 
CD8
 
 
 
 double negative (DN) stage. To test 
the importance of this, we expressed the HY
 
 
 
 chain at the physiological CD4
 
 
 
CD8
 
 
 
 double 
positive (DP) stage. The reduced DP and increased DN cellularity typically seen in TCR 
transgenics was not observed when the 
 
 
 
 chain was expressed at the appropriate stage. 
Surprisingly, antigen-driven selection events were also altered. In male mice, thymocyte 
deletion now occurred at the single positive or medullary stage. In addition, no expansion of 
CD8
 
  
 
 intestinal intraepithelial lymphocytes (IELs) was observed, despite the fact that HY 
transgenics have been used to model IEL development. Collectively, these data establish the 
importance of proper timing of TCR expression in thymic development and selection and 
emphasize the need to use models that most accurately reflect the physiologic process.
 
During T cell development, progenitors seed
the thymus from the blood and begin a se-
quential program of maturation marked by
changes in cell surface phenotype (for review
see reference 1). The earliest progenitors lack
expression of the CD4 and CD8 coreceptors
and are therefore termed double negative
(DN). DN thymocytes can be further subdi-
vided based on the expression of CD44 and
CD25 into DN1–DN4 stages. The DN3 stage
of development is where thymocytes must pass
their first test of fitness, 
 
 
 
-selection. If TCR
 
 
 
gene rearrangement is successful, the polypep-
tide chain pairs with an invariant pre-TCR
 
 
 
and signals the thymocyte to undergo further
differentiation. The events of 
 
 
 
-selection in-
clude survival, proliferation, differentiation,
and allelic exclusion at the TCR
 
 
 
 locus. At
this point, the progenitor also up-regulates
CD4 and CD8 to become double positive
(DP) and initiates rearrangement at the TCR
 
 
 
gene locus. If a productive TCR
 
 
 
 gene rear-
rangement occurs, the 
 
 
 
 chain can pair with
the already expressed TCR
 
 
 
 chain and be ex-
pressed on the surface. All subsequent selection
events are based on the antigen binding site
formed by this heterodimer. It is currently
held that thymocytes bearing a TCR with
high affinity for self-MHC–peptide complexes
are deleted from the repertoire, whereas those
with a low affinity are positively selected. If
the TCR has negligible affinity for self-MHC,
the thymocyte undergoes death by neglect. A
key feature of these selective events and a hall-
mark of T cell development is the ordered and
sequential rearrangement and expression of the
TCR
 
 
 
 and TCR
 
  
 
chains, respectively. This
highly regulated process ensures the produc-
tion of a clonally expressed repertoire with a
minimum of energy expenditure.
Despite the normally sequential expression
of TCR
 
 
 
 and -
 
 
 
 in normal mice in most
TCR transgenic model systems both TCR
 
 
 
and -
 
 
 
 chains are expressed early in develop-
ment. This early expression of TCR
 
 
 
 has
been suggested to affect 
 
 
 
-selection even in
the presence of the pre-TCR because TCR
 
 
 
has a higher affinity for TCR
 
 
 
 than it does for
pre-T
 
 
 
 (2). Although the 
 
  
 
TCR heterodimer
can mediate 
 
 
 
-selection if expressed at the DN
stage, it is highly inefficient (3). In addition,
early expression may affect 
 
  
 
/
 
  
 
 lineage
commitment, resulting in a large population of
mature DN TCR
 
 
 
 cells both in the thymus
and the periphery (4–7). In the thymus, these
cells are thought to represent a terminally dif-
ferentiated population without the ability to
seed the DP compartment (6). In the periph-
ery, DN TCR
 
 
 
 cells display properties consis-
tent with a 
 
  
 
-lineage cell (7). These lineage-
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misdirected cells are not observed in wild-type mice or mice
that express a transgenic TCR
 
 
 
 chain. Therefore, it has
been suggested that early TCR
 
 
 
 expression results in the
previously mentioned abnormalities.
To directly test this, we sought to create a model in
which TCR
 
 
 
 expression would be delayed until the DP
stage (as is the case in normal animals). Using a Cre/lox-
based conditional strategy, we expressed the HY TCR
 
 
 
 at
the DP stage of development (HY
 
cd4
 
 mice). In this model,
the defects in 
 
 
 
-selection and lineage commitment observed
in conventional HY transgenics were corrected. Other de-
velopmental characteristics, including positive selection and
lymphopenia-induced proliferation, were unchanged. Inter-
estingly, in HY
 
cd4
 
 male mice, clonal deletion did not occur
until the single positive (SP) stage, despite antigen encounter
at the DP stage. In addition, the prominent expansion of
CD8
 
  
 
 
 
 intraepithelial lymphocytes (IELs) observed in
conventional HY male mice was not apparent in HY
 
cd4
 
mice. These observations suggest that certain properties of
conventional TCR transgenics are nonphysiologic and dem-
onstrate that T cell selection is critically influenced by the
appropriate timing of TCR
 
 
 
 expression.
 
RESULTS
Conditional expression of HY TCR
 
To conditionally express the HY TCR
 
 
 
 chain at the DP
stage, we used the CD4 promoter-enhancer. However, be-
cause this promoter is not active in mature CD8 T cells, we
combined it with a Cre/lox-based strategy. The HY TCR
 
 
 
was cloned immediately downstream of a transcriptional and
translation “STOP” cassette flanked by loxP sites. After re-
moval of the STOP cassette by Cre-mediated recombination,
a constitutively active promoter, pCAGGS, drives transcrip-
tion of the HY TCR
 
 
 
 (Fig. 1 A). By this strategy, expression
of HY TCR
 
 
 
 should be completely dependent on Cre ex-
pression from the CD4 promoter but not extinguished in
CD8 T cells. Transient cotransfection of the conditional HY
TCR
 
 
 
 construct and a Cre expression vector into the TCR
 
 
 
BW5147 58
 
 
 
/
 
 
 
 hybridoma cell line indicated that expression
of HY TCR
 
 
 
 was dependent on the presence of Cre (un-
published data). Previous data indicated that in CD4–Cre
mice, Cre-mediated recombination was initiated at the late
DN3 stage and completed at the DN4 stage (8, 9). Therefore,
by using CD4-driven Cre, we predicted that HY TCR
 
 
 
would not be expressed until after 
 
 
 
-selection, which fairly
accurately mimics when endogenous TCR
 
 
 
 rearrangement
and expression occur. Conditional HY TCR
 
 
 
 mice were
created, crossed to CD4–Cre mice, and bred to HY TCR
 
 
 
transgenic mice. Mice bearing all three transgenes are referred
to as HY
 
cd4
 
 mice. Although the construct encodes a bicis-
tronic message containing GFP, no GFP expression was ob-
served (unpublished data), similar to a conditional construct
reported previously (10). HY
 
cd4
 
 mice showed no gross abnor-
malities in the CD4/CD8 thymic profile (Fig. 1 B, top). The
CD44/CD25 profile of DN thymocytes from HY
 
cd4
 
 mice
was similar to HY
 
 
 
-only mice, which display a slight acceler-
ation through the DN subsets (Fig. 1 B, bottom). To deter-
mine when the HY 
 
  
 
TCR is expressed at the cell surface of
thymocytes, thymic subpopulations were electronically gated
and examined for HY TCR
 
 
 
 expression using the T3.70 an-
tibody (11). T3.70 staining was observed in the DP and
CD8SP subsets and to a lesser extent in CD4SP cells (Fig. 1
C). As predicted, no T3.70 expression was observed in the
bulk DN compartment (Fig. 1 C) or in any DN subcompart-
Figure 1. Conditional expression of the HY TCR beginning at the 
DP stage in HYcd4 mice. (A) Schematic representation of the conditional 
HY TCR  transgene. (B) Thymocytes from the indicated mice were stained 
with either anti-CD4 and anti-CD8 (top) or with anti-CD4, -CD8, -B220, 
and –NK1.1 to exclude lineage-positive cells and with anti-CD44 and anti-
CD25 (bottom). Cells were analyzed by flow cytometry. Numbers represent 
the percentage of cells in each gate. (C) Thymocytes from B6 (shaded 
region), HY female (dotted line), and HYcd4 female (continuous line) were 
stained with anti-CD4, anti-CD8, and T3.70 and analyzed by flow cytometry. 
Individual subpopulations were gated, and T3.70 expression is depicted. 
(D) Thymocytes from B6 (shaded region), HY female (dotted line), and 
HYcd4 female (continuous line) were stained with anti-CD4, -CD8, -B220, 
and -NK1.1 to exclude lineage-positive cells and with anti-CD44, anti-
CD25, and T3.70 to allow electronic gating of the DN subpopulations. 
T3.70 expression is depicted for the individual DN subpopulations. The y 
axes in C and D represent the percentage of maximum expression. 
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ment (Fig. 1 D). This is in contrast to conventional HY TCR
transgenic mice that express the TCR
 
 
 
 chain as early as the
DN2 stage (Fig. 1 D). Although there was expression of con-
ventional HY TCR in DN1 phenotype cells, this subset is
heterogenous (12), and it is unclear if canonical DN1 progen-
itors express it. We also observed a slightly reduced level of
surface TCR in all subsets of HY
 
cd4
 
 mice when compared
with conventional HY mice (Fig. 1 C), which could be
caused by the strength of the ubiquitous promoter chosen.
When comparing with wild-type thymocytes, the HY
 
cd4
 
 DP
TCR levels were closer: HY DPs express 4–5-fold more re-
ceptor, whereas HY
 
cd4
 
 DPs express only 2.5–3-fold more re-
ceptor (Fig. S1, available at http://www.jem.org/cgi/con-
tent/full/jem.20050359/DC1). In the CD8SP compartment,
HY
 
cd4
 
 thymocytes expressed approximately half the level of
TCR as the wild type, whereas HY thymocytes expresses
similar levels (Fig. S1). Overall, as predicted, the HY TCR
complex was expressed beginning at the DP stage and con-
tinued through the CD8SP stage in HY
 
cd4
 
 mice.
 
Corrected 
 
 
 
-selection and lineage commitment 
in HY
 
cd4
 
 mice
 
Early expression of a mature TCR was proposed to result in
impaired 
 
 
 
-selection and altered lineage commitment in HY
and other TCR transgenics (5, 6, 13). Therefore, we wished
to determine whether delaying TCR
 
 
 
 expression until the
DP stage corrected these events. Because little or no cell di-
vision occurs in the DP and SP compartment, the total num-
ber of thymocytes present in the thymus largely reflects the
proliferative burst that accompanies 
 
 
 
-selection. The thymic
cellularity of HY
 
cd4
 
 female mice was equivalent to that of B6
mice, whereas conventional HY female mice showed a two-
to threefold reduction in total thymocyte numbers (Fig. 2 A,
left). Additionally, 
 
 
 
-selection mediated by an 
 
  
 
TCR, as
opposed to a pre-TCR, resulted in an increase in annexin
V
 
 
 
 cells in the DN4 compartment (3). By expressing HY
TCR
 
 
 
 at the DP stage, we found a similar percentage of an-
nexin V
 
 
 
 DN4 cells as in wild-type mice, whereas the early
TCR
 
 
 
 expression observed in conventional HY mice re-
sulted in a 5–10-fold increase in annexin V
 
 
 
 DN4 cells (Fig.
2 A, right). These results provide further evidence that the
early expression of an 
 
  
 
 heterodimer impairs 
 
 
 
-selection.
It has additionally been suggested that 
 
  
 
/
 
  
 
 lineage
commitment is disrupted by early expression of TCR
 
 
 
, re-
sulting in mature 
 
  
 
TCR
 
 
 
 DN cells in both the thymus
and periphery (5, 7, 13). In examining the thymic DN com-
partment, conventional HY female mice had a large number
of resident 
 
  
 
TCR
 
 
 
 cells, whereas this population was sub-
stantially reduced in wild-type and HY
 
cd4
 
 mice (Fig. 2 B,
left). As cells mature, the expression of CD24 (heat-stable
antigen) decreases with the most mature thymic cells being
CD24
 
lo
 
. No difference in CD24 levels between wild-type
and HY
 
cd4
 
 mice was observed (Fig. 2 B, right). However,
the vast majority of conventional HY mice had lower levels
of CD24, suggesting that they are more mature and may
comprise a population of lineage-misdirected cells (so-called
“
 
  
 
-wannabes”; Fig. 2 B, right). Mature 
 
  
 
TCR
 
 
 
 DN cells
are also prominent in the periphery of conventional HY
mice and, again, were absent in HY
 
cd4
 
 mice (Fig. 2 C). Col-
lectively, these data suggest that delaying TCR
 
  expression
in a transgenic mouse allows  -selection and early lineage
commitment to occur normally.
Timing of TCR  does not appear to affect positive selection 
or homeostatic proliferation (HP)
It was unclear at this point whether or not early expression
of TCR  would affect positive selection events. By first gat-
Figure 2.  -selection and lineage misdirection is corrected in 
HYcd4 mice. (A) Total thymocyte numbers from B6 (107   25   106), HY 
female (56   14   106), and HYcd4 female (123   38   106) are shown 
(left). Thymocytes were stained with anti-CD4, -CD8, -B220, and -NK1.1 to 
exclude lineage-positive cells. The horizontal line represents the mean. 
Anti-CD44, anti-CD25, and annexin V staining were performed to identify 
apoptotic cells in the DN4 compartment (right). Data are expressed as a 
ratio of the percentage of annexin V  DN4 cells compared with B6. Error 
bar represents SD. (B) DN thymocytes were analyzed for TCR  or CD24 
expression. The number of DN TCR  cells from B6 (6.7   1.8   105), HY 
female (11   1.7   106), and HYcd4 female (9.0   1.8   105) (left; error 
bar represents SD) or the expression level of CD24 on B6 (shaded region), 
HY female (dotted line), and HYcd4 female (continuous line) (right; y axis 
represents the percentage of maximum expression) was determined. 
(C) LN cells from the indicated mice were stained with anti-CD4, anti-CD8, 
H57-597 (anti-TCR ), and T3.70. The percentage of CD4 CD8  cells 
expressing T3.70 (HY female and HYcd4 female) or TCR  (B6) was assessed 
(left). Additionally, the CD4/CD8 profile of T3.70  LN cells is shown for HY 
female and HYcd4 female mice (right). The numbers within the FACS plots 
represent the percentage of cells within that gate.AN “ON-TIME” TCR TRANSGENIC MODEL | Baldwin et al. 114
ing on T3.70  cells and then examining the CD4/CD8 dis-
tribution, we observed a prominent CD8SP population, in-
dicating positive selection in HYcd4 female mice, as in the
conventional model (Fig. 3 A). The population of T3.70 
CD8SPs was somewhat lower in both percentage and num-
ber in HYcd4 mice compared with conventional HY mice,
suggesting a reduced efficiency. The reason for this differ-
ence is currently unclear; however, it could be caused by en-
dogenous TCR gene rearrangements, which are likely to be
more prevalent when the transgene comes on later. Indeed,
the phenotype of HYcd4TCR  /  mice (see Fig. 5 C) sup-
ports this. Positive selection is known to induce changes in
gene expression that can be monitored by changes in the cell
surface phenotype of DP thymocytes, including up-regula-
tion of CD69, CD5, and CD2, and down-regulation of
heat-stable antigen. Compared with B6 DP thymocytes,
both conventional HY and HYcd4 DP thymocytes up-regu-
lated CD69, CD5, CD2 (Fig. 3 B), and CD53 (not depicted)
to a similar extent. In the CD8SP compartment, both
showed a reduction in CD24, similar to wild-type controls
(Fig. 3 B). Examination of the LNs from conventional HY
and HYcd4 mice indicated the presence of CD8  T3.70 
cells (Fig. 3 C). Although there was a slight difference in the
percentage of CD8  T3.70  cells in the LNs and in the
number of T3.70  CD8  cells in the spleens of conventional
HY and HYcd4 mice (Fig. 3 C), this difference is likely at-
tributable to a reduced number of T3.70  CD8s exiting the
thymus in HYcd4 mice because not all progenitors express
the HY TCR  chain (Fig. 1 C). Additionally, the level of
CD5 expressed by T3.70  LN CD8 cells was equivalent in
HY and HYcd4 mice, suggesting that the “tuning” of the
TCR signal is similar in both strains of mice (Fig. 3 C).
To survive in the periphery, CD8 cells must receive a
tonic signal through the TCR (14). The ability to undergo
HP has an effect on the number of cells present in the periph-
ery and has been suggested to correlate with TCR affinity
and, thus, the level of CD5 expressed on peripheral CD8 T
cells (15). HY transgenic CD8 T cells have a notable ineffi-
ciency in this homeostasis, particularly in lymphopenic recip-
ients (16), that could either be caused by an inherently low
affinity for self-antigen or by some other nonphysiologic as-
pect of the conventional HY transgenic model, such as early
expression of the TCR  chain in development. Thus, we
evaluated the capacity of CD8SP thymocytes to undergo HP
in lymphopenic recipients. CD8SP thymocytes were used in
this assay because this cell population is phenotypically equiv-
alent between the two mouse strains, and the cells had not
yet undergone any competition with other peripheral T cells.
Carboxyfluorescein diacetate succinimidyl ester (CFSE)–
labeled bulk thymocytes from HYcd4 or conventional HY
thymocytes mixed with B6 thymocytes were injected into sub-
lethally irradiated congenic recipients and parked for 9 d. B6
thymocytes were mixed with conventional HY thymocytes
to provide a reference population for determining the extent
of HP because the CD8SP pool of thymocytes from HYcd4
mice contain T3.70  cells with a polyclonal repertoire. Nei-
ther the T3.70  CD8 cells from conventional HY mice nor
those from HYcd4 mice underwent HP (Fig. 3 D), as was pre-
viously reported (17). Control polyclonal cells did undergo
division as measured by CFSE dilution. Overall, these data
suggest that positive selection and HP are not affected by
early expression of TCR .
Antigen sensitivity of DP and CD8SP thymocytes are 
identical in conventional HY and HYcd4 mice
Because of the reduction in TCR levels, we wanted to ex-
amine the antigen sensitivity of T3.70  CD8SP cells from
HYcd4 mice. Total thymocytes were cultured at a 1:1 ratio
Figure 3. Positive selection and HP are not affected by early TCR  
expression. (A) Thymocytes from HY female and HYcd4 female mice were 
stained with anti-CD4, anti-CD8, and T3.70 and analyzed by flow cytometry. 
The CD4/CD8 profile of T3.70  cells is shown. The numbers within the FACS 
plots represent the percentage of cells within that gate. (B) T3.70  DP or 
CD8SP thymocytes from B6 (shaded region), HY female (dotted line), and 
HYcd4 female (continuous line) were assessed for levels of CD69, CD5, CD2, 
and CD24. (C) LN cells from B6 (shaded region), HY female (dotted line), and 
HYcd4 female (continuous line) mice were stained with anti-CD4, anti-CD8, 
T3.70, and CD5. The level of T3.70 on gated CD8 cells (left) and CD5 on 
gated CD8  T3.70  cells (middle) is shown. The numbers in the left panel 
indicate the percentage of T3.70hi CD8 cells. The right panel shows the ab-
solute number of CD8  T3.70hi splenocytes from HY female (1.0   0.6   106) 
and HYcd4 female (3.5   3   105) mice. Error bars represent SD. (D) Bulk 
thymocytes from HYcd4 female (continuous line) or a mixture of B6 (shaded 
region) and HY female (dotted line) thymocytes were CFSE labeled and 
adoptively transferred into sublethally irradiated B6.SJL mice. Recipient 
mice were harvested 9 d after transfer and CD45.2  CD8  T3.70  cells 
were analyzed for CFSE dilution. CD45.2  CD8  T3.70  cells were used as 
an internal control. Representative data from one recipient mouse out of 
three receiving either HYcd4 female or B6/HY female cells are shown. The y 
axes in B–D represent the percentage of maximum expression.JEM VOL. 202, July 4, 2005 115
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with B6 splenocytes and increasing doses of agonist peptide,
smcy, in vitro for 20 h, and the response of T3.70  CD8SP
cells was evaluated by CD69 induction. Both T3.70  DP
and CD8SP thymocytes from conventional HY and HYcd4
mice responded equivalently to agonist peptide at all con-
centrations (Fig. 4 A). Additionally, the T3.70  CD8SP di-
vided similarly in response to 100 nM smcy as measured by
CFSE dilution (unpublished data). To compare the func-
tional potential of HY and HYcd4 cells in vivo, bulk thy-
mocytes were CFSE labeled and injected i.v. into intact male
or female recipients. 2 d after transfer, the LNs and spleens of
the recipient mice were harvested and the CFSE dilution of
the CD8SP T3.70  cells was determined. Both HY and
HYcd4 cells diluted CFSE equivalently in male recipients
(Fig. 4 B). Therefore, despite a twofold difference in surface
TCR levels, the antigen responsiveness of cells from HY and
HYcd4 mice appears equivalent.
Negative selection occurs late in development in HYcd4 mice
Some discrepancy exists in the literature regarding the tim-
ing of negative selection during development. In wild-type
mice, superantigen-mediated deletion generally occurs late
in development, as DP mature into SP cells, whereas in
other models, particularly some transgenic models (including
the conventional HY model), deletion occurs early, either
right at or preceding DP generation. Examination of the
CD4/CD8 profile of T3.70  cells in the thymus revealed
striking differences between conventional HY and HYcd4
male mice. The overwhelming majority of T3.70  cells in
conventional HY male mice were of the DN phenotype
with virtually no DP, CD4SP, or CD8SP populations (Fig. 5
A). In contrast, in HYcd4 male mice, T3.70  cells were pre-
dominantly DP thymocytes with very few CD8SP cells (Fig.
5 A). Comparing HYcd4 female to HYcd4 male T3.70  thy-
mocytes, there was no difference in the percentage of DP
cells, whereas there was a dramatic loss of CD8SP cells in
HYcd4 male mice (Fig. 5 A). To confirm that this phenotype
was dependent on the timing of HY TCR expression and
not some other variable of the conditional expression strat-
egy, we also examined HYlck animals. In this strain, Cre is
driven by the lck promoter and results in HY TCR expres-
sion in the early DN stage, which is similar to conventional
HY mice (unpublished data). Indeed, the thymus of the
HYlck male animal resembled the conventional HY male
thymus, where the majority of T3.70  cells were DN (Fig.
S2 A, available at http://www.jem.org/cgi/content/full/
jem.20050359/DC1). The difference between the conven-
tional HY and HYcd4 strains was further highlighted when
comparing the number of T3.70  cells in the DP and
CD8SP populations from the various mice. There was an
 500–1,000-fold reduction in DP thymocytes when com-
paring conventional HY male and female mice, whereas
only a 2-fold reduction in the numbers of DP thymocytes is
observed between HYcd4 male and female mice (Fig. 5 B).
Again, very few T3.70  DP thymocytes were present in
HYlck males (Fig. S2 B), suggesting that this difference is
caused by the timing of TCR  gene expression. The reduc-
tion in HYcd4 mice was predominantly seen in the CD8SP
compartment, which is 15-fold smaller in HYcd4 male com-
pared with female mice (Fig. 5 B). Thus, although male anti-
gen-mediated deletion occurs at the DN–DP transition in
the conventional HY model, it occurred at the DP–SP tran-
sition in the HYcd4 model, and this difference was caused by
the timing of TCR  expression.
To rule out the possible contribution of endogenous
TCR  chains to our observations, we constructed bone
marrow chimeras with HYcd4 TCR   female bone marrow.
We created mixed chimeras with either B6.PL male or fe-
male bone marrow and injected them into male or female
B6.PL recipients, respectively, to provide male antigen-
expressing, bone marrow–derived, antigen-presenting cells.
The only difference in the CD4/CD8 profile of T3.70  cells
from the thymus of HYcd4 mice on a TCR -sufficient or
-deficient background was a slightly enhanced CD8 percent-
age in the females (Fig. 5 C). A large population of T3.70 
DP, with an absence of CD8SP, was still observed in the
male. Additionally, the relative chimerism of the DP and
CD8SP compartments in male and female recipients sup-
ported late deletion (unpublished data).
Figure 4. In vitro and in vivo responsiveness of HY and HYcd4 CD8 
thymocytes is equivalent. (A) Bulk thymocytes from HY female (black 
line) or HYcd4 female (gray line) mice were mixed at a 1:1 ratio with female 
B6 splenocytes and increasing concentrations of agonist smcy peptide 
were added to the culture and incubated for 20 h. Cells were harvested 
and stained with anti-CD4, anti-CD8, T3.70, and anti-CD69 and analyzed 
by flow cytometry. CD4 CD8 T3.70hi (left) and CD4 CD8 T3.70  (right) 
cells were gated, and the induction of CD69 was measured. Data are ex-
pressed as a percentage of cells that maximally up-regulated CD69. (B) HY 
female (left) or HYcd4 female (right) bulk thymocytes were CFSE labeled 
and injected i.v. into intact female (shaded region) or male (continuous 
line) recipients. 48 h after injection, spleens were harvested, and the CFSE 
dilution of CD8  T3.70  cells was measured. The y axis represents the 
percentage of maximum expression.AN “ON-TIME” TCR TRANSGENIC MODEL | Baldwin et al. 116
No difference in the level of T3.70 expression was ob-
served between HYcd4 male and female DP cells (Fig. 5 D).
Thus, it is possible that T3.70  DP cells are present in HYcd4
male mice because they have yet to encounter antigen (e.g.,
because of a lack of presentation by cortical epithelial cells).
However, this does not appear to be the case because CD69
was expressed at a high level in HYcd4 T3.70  male DP cells,
indicating that those cells had in fact responded to antigen but
were not yet deleted (Fig. 5 D). Additionally, an examination
of the few remaining T3.70  CD8SP cells in HYcd4 male
mice revealed a high expression of CD24, indicating an im-
mature state (Fig. 5 D). Collectively, these data indicate that
early expression of HY TCR  in conventional HY male
mice leads to immediate and early deletion, whereas HY
TCR  expression at the DP stage leads to a later and delayed
deletion, which occurs as cells transition from DP to SP.
CD8   IEL expansion occurs less in HYcd4 male mice
There is a unique population of lymphocytes in the gut that
express   TCR and CD8   homodimers. A great deal of
debate has surrounded the issue of how this population de-
velops. Although it was thought that CD8   IELs develop
extrathymically, this might only be the case in lymphopenic
conditions (18); other evidence suggests a thymic origin
(19). Additionally, this population is thought to be self-reac-
tive and to serve a regulatory function in the gut (20). In-
deed, consistent with this idea, conventional HY male mice
display at least a 100-fold expansion in CD8   IELs (21,
22). Nevertheless, it remains controversial as to whether
CD8   IELs develop from DN or DP progenitors. We felt
that our model would be a good means to evaluate this issue.
To this end, we purified IELs according to standard pro-
tocols and evaluated the number and percentage of T3.70 
CD8   IELs in the different transgenic strains. As previously
reported, the number of T3.70  CD8   IELs was  500-fold
higher in conventional HY male mice compared with females
(Fig. 6 A; references 21 and 22). In contrast, there was only a
fivefold change in the number of these cells between male and
female HYcd4mice, which was not significant with the num-
ber of animals analyzed (P   0.05; Fig. 6 A). Examination of
HYlck mice showed a 200-fold increase in T3.70  CD8  
IELs in males over females, similar to conventional HY trans-
genics, further suggesting that the timing of TCR  expres-
sion is critical for the expansion of these cells (Fig. S2 D). Ad-
ditionally, the T3.70  IELs from HYcd4 mice showed a similar
percentage of CD8  - and CD8  -expressing cells in both
males and females, whereas there was a dramatic increase in
CD8  -expressing cells in conventional HY and HYlck male
mice (Fig. 6 B and Fig. S2 D). Curiously, the IELs from
HYcd4 male mice display a small CD8  hi population that is
not present in HY or HYlck males, of which we do not un-
derstand the importance at this time.
To determine whether early versus late TCR expression
has an impact on the phenotype of T3.70  CD8   IELs, we
examined the expression pattern of several molecules re-
ported to be differentially expressed on CD8   versus
CD8   IELs by the gene profiling (23). CD8   and
CD8   IELs from B6 display distinct patterns of CD5,
Figure 5. Deletion occurs late in HYcd4 male mice. (A) Thymocytes from 
the indicated mice were stained with anti-CD4, anti-CD8, and T3.70 and ana-
lyzed by flow cytometry. The T3.70  thymocytes were gated and the CD4/
CD8 profile is indicated. The numbers within the FACS plots represent the 
percentage of cells falling within that gate. (B) Comparisons of the absolute 
number of DP (HY female, 30   7.6   106; HY male, 9.0   5   104; HYcd4 
female, 53   18   106; HYcd4 male, 23   12   106), and CD8SP (HY female, 
10   4   106; HY male, 5.3   3.3   105; HYcd4 female, 4.4   1.4   106; HYcd4 
male, 3.4   1.9   105) T3.70  thymocytes from the different mouse strains. 
(*, P   0.0001; **, P   0.002). The horizontal lines represent the means. 
(C) Bone marrow from HYcd4 TCR o female mice was mixed with either female 
or male B6.PL bone marrow, and 7   106 cells were injected i.v. into lethally 
irradiated female or male B6.PL recipients, respectively. The female (left) and 
male (right) recipients were harvested 5–8 wk after transfer. CD4/CD8 pro-
file of Thy1.2  cells is indicated. (D) DP and CD8SP thymocytes from B6 
(shaded region), HY female (dotted line), HYcd4 female (continuous line), and 
HYcd4 male (dashed line) mice were analyzed by flow cytometry for T3.70 
expression (far left and left). T3.70  DP (right) and T3.70  CD8SP (far right) 
were assessed for CD69 up-regulation and CD24 down-regulation, respec-
tively. The y axis represents the percentage of maximum expression.JEM VOL. 202, July 4, 2005 117
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CD122, and CD11a (Fig. S3, available at http://www.jem.
org/cgi/content/full/jem.20050359/DC1). Interestingly, the
level of expression of these markers on T3.70  CD8   IELs
from both conventional HY and HYcd4 males was not similar
to either normal population (Fig. S3). In fact, for all three
markers, the level of expression was intermediate between
CD8   and CD8   IELs from B6 (Fig. S3). The reason for
this difference is also currently unclear. Together, these data
suggest that the expansion of T3.70  CD8   IELs in re-
sponse to high affinity ligand is dependent on TCR expres-
sion early in development. Furthermore, CD8   IELs that
do develop in conventional HY or HYcd4 male mice have an
unusual phenotype when compared with nontransgenic
CD8   IELs.
If CD8   IEL expansion requires TCR gene rearrange-
ment and expression at the DN stage, then one would pre-
dict that such cells would not be prominent in HY  trans-
genic mice. HY  transgenic mice express only the TCR 
chain early in development. The TCR  chain is derived
from the endogenous repertoire, which does not undergo
gene rearrangement and expression until the DP stage. Thus,
potential male reactive receptors are not generated until the
DP stage. Female HY  transgenic mice displayed a promi-
nent population of male reactive CD8  cells in the LNs as
judged by their ability to bind Db/male antigen tetramers
(Fig. 6 C; reference 24), which are presumably derived by
positive selection at the DP stage. If self-reactivity were to
result in the positive selection of CD8   IELs in HY  mice,
then CD8   IELs from male mice should display an in-
crease in male reactivity. This was not the case, as CD8  
IELs from male HY  mice do not show detectable Db–smcy
pentamer binding (Fig. 6 D). This does not reflect a techni-
cal inability of CD8   cells to bind pentamers because the
CD8   IELs from HY conventional mice do bind the pen-
tamer (Fig. 6 D). This result confirms the findings from the
HYcd4 mouse and suggests that development of CD8   IELs
in HY mice depends on early rearrangement and expression
of the TCR.
DISCUSSION
Our data indicate that early expression of the TCR affects
several properties in TCR transgenic mice. This is important
because TCR transgenics represent the predominant tool
used to study lymphocyte development, particularly as it re-
lates to the specificity and affinity of the rearranged antigen
receptor. When the male-specific HY TCR was expressed at
the physiological DP stage of development, the  -selection
defect and lineage misdirection seen in conventional TCR
transgenics was corrected. Furthermore, deletion occurred
late in development and expansion of the CD8    gut IELs
was lost. Positive selection and HP were unaffected by early
TCR expression. In general, we feel this model represents a
more faithful recapitulation of T cell development processes.
 -selection and lineage misdirection
 -selection is a process initiated by the pre-TCR at the
DN3 stage. It signals the successful completion of TCR 
chain gene rearrangement and results in cellular expansion,
CD4 and CD8 expression, termination of further TCR 
chain gene rearrangement, initiation of TCR  chain gene
rearrangement, migration into the cortex, and development
of positive and negative selection “competence” factors (25,
26). Although a mature   TCR is capable of inducing
 -selection at the DN stage, it is much less efficient than that
mediated by the pre-TCR (3). In HYcd4 mice, the  -selec-
tion impairment seen in conventional HY mice did not oc-
cur. This finding is consistent with a pre-T  competition
model, where a higher affinity of TCR  for TCR , com-
pared with pre-T , results in less efficient  -selection. In
support of this hypothesis, studies by Lacorazza et al. have
indicated that premature TCR expression impairs the prolif-
erative burst of DN thymocytes and increases the number of
terminally differentiated DNs (6).
Figure 6. Early TCR  expression is required for expansion of gut 
CD8   IELs. (A) IELs were isolated and stained with anti-CD8 , -CD8 , 
-CD3, and T3.70 and analyzed by flow cytometry. CD3  T3.70  cells were 
electronically gated and the absolute number of CD8    cells was 
quantified by comparison to the acquisition of a known number of latex 
beads included in the sample (HY female, 4.1   3.6   103; HY male, 
1.5   2.1   106; HYcd4 female, 3.7   5.8   103; HYcd4 male, 4.8   8.6   
104). The horizontal lines represent the means. *, P   0.05; **, P   0.05. 
(B) CD8 /CD8  profile of the CD3  T3.70  IELs is shown for the indi-
cated mice. The numbers within the FACS plots represent the percentage 
of cells falling within that gate. (C) LN cells from B6 (shaded region), 
HY  female (dashed line), and HY  male (continuous line) mice were 
stained with anti-CD8 , -CD8 , -CD3, and Db–smcy pentamer. Db–smcy 
pentamer staining for CD3  CD8    cells is indicated. (D) IELs were 
harvested from B6 (shaded region), HY  male (continuous line), and HY 
male (dotted line) mice and stained with anti-CD8 , -CD8 , -CD3, and 
Db–smcy pentamers. Db–smcy pentamer staining from CD3  CD8    
cells is indicated. The y axes in C and D represent the percentage of 
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In the periphery of conventional HY mice, there is a
large population of DN T3.70  cells. These cells have been
shown to represent lineage-misdirected cells, arising because
of signals from the   TCR at the DN stage as would be the
case if a   TCR were expressed (4, 13). When the HY
TCR was not expressed until the DP stage, this population
of cells was absent. Importantly, some studies have suggested
that these DN TCR  cells have regulatory potential (27,
28). Because the DN cells have the same specificity as the
CD8 or CD4 cells in the periphery, they have the potential
to influence the immune response in a nonphysiologic man-
ner if intact TCR transgenics are used to evaluate an anti-
gen-specific response. This, however, is not a concern when
the adoptive transfer of purified CD8 or CD4 transgenic
cells is used to evaluate an antigen-specific response.
Positive selection and homeostasis
Early TCR expression does not seem to affect positive selec-
tion or homeostasis. We found no differences in the pheno-
types of T3.70  DP or CD8SP cells in HYcd4 mice compared
with conventional HY mice. In both cases, markers shown to
be up-regulated in response to TCR stimulation, including
CD69, CD2, CD5, and CD53, were all induced to the same
extent. Additionally, T3.70  CD8SP cells responded equiva-
lently in vitro and in vivo to agonist ligand. Evaluation of the
HP potential of T3.70  CD8SP thymocytes revealed that
cells from neither model were able to divide in response to
lymphopenic conditions, which has been previously demon-
strated for conventional HY cells (17). The reason for this
lack of HP is currently unclear; however, at least two differ-
ent explanations can be offered. First, it is possible that the se-
lecting ligand in the thymus is either absent or reduced in
quantity in the periphery. Work by Santori et al. identified,
through homology-based searches, a peptide that could select
HY TCR thymocytes in fetal thymic organ culture, but it is
unclear if, where, and in what quantities this peptide is pre-
sented in the periphery (29). Alternatively, it has been sug-
gested that the failure of HY T cells to undergo HP is caused
by the low affinity of the HY TCR for the selecting ligand
(15). This reasoning stems from the observation that both pe-
ripheral CD8s and CD8SP thymocytes express lower levels of
CD5 than do bulk B6 thymocytes or other TCR transgenics
that do undergo HP. We find this possibility somewhat un-
likely since positive selection of HY thymocytes does occur
and appears to be quite efficient. We favor a combination of
these two hypotheses in which the affinity of the HY TCR
for the selecting ligand is somewhat lower than for other
TCR transgenics, as illustrated by reduced CD5 levels, but
still high enough to mediate positive selection, and the ex-
pression of this ligand is limited in the periphery. Further ex-
periments are necessary to understand this issue fully.
Clonal deletion
Perhaps some of the most intriguing results were obtained
when examining T cell development in male HYcd4 mice.
We observed that negative selection in HYcd4 male mice oc-
curs late in development, at the DP to CD8SP transition.
Discrepancies exist in the literature regarding the timing of
negative selection. Some models, including the conventional
HY and other TCR transgenic models, find that negative se-
lection occurs immediately at or preceding DP generation.
However, deletion in other transgenic models (30–32), as
well as endogenous superantigen-mediated deletion (33, 34),
occurs at the DP–SP transition, as is found in the HYcd4
model. In addition, analysis of the anatomy of apoptosis in
MHC-sufficient versus -deficient mice suggests that deletion
is primarily cortico-medullary (35), corresponding to a late
deletion at the DP or SP stage. Based on the findings here,
we hypothesize that the early deletion seen in some TCR
transgenic models of negative selection is caused by the non-
physiologic early TCR expression. Clearly, the anatomical
location of self-antigen can be a factor in when negative se-
lection occurs. However, because the male self-antigen is
ubiquitously expressed in the thymus, and its presentation
does not vary between conventional HY, HYlck, and HYcd4
models, the timing of TCR expression appears to be a more
critical factor in when negative selection occurs.
One surprising feature of the response to male antigen in
the HYcd4 model is the presence of a large population of ac-
tivated DP progenitors. In conventional HY male mice, it is
difficult to find progenitors (DN or DP) with an activated
phenotype, presumably because they had undergone imme-
diate apoptosis. This implies that the death induced in the
more physiologic HYcd4 model is somehow delayed. Previ-
ous studies have suggested that the medulla and cortico-
medullary junction is the primary site for clonal deletion to
superantigen (35) or to the complement component C5 in
A18 TCR transgenic animals (36), and genetic studies sug-
gest that costimulatory molecules that are expressed in the
medulla, but not the cortex, are important for clonal dele-
tion (37–40). Therefore, an interesting possibility is that self-
antigen–specific progenitors normally do not undergo clonal
deletion until they migrate to the cortico-medullary junc-
tion, a possibility that could be evaluated by determining the
site of deletion in the HYcd4 model.
In addition to there being discrepancies about the stage
of deletion, there is also controversy about the molecular
signaling pathways leading to deletion. For example, the role
of CD40–CD40L interaction has been demonstrated to be
necessary in some models of deletion, yet appears to be dis-
pensable in others (including the conventional HY model;
reference 41). Other molecules, including TNFR, CD28,
and Fas, also have controversial roles in negative selection
(42). Because deletion occurs late in the HYcd4 model it may
be interesting to reevaluate the role of these molecules in
central tolerance to male antigens.
CD8   IELs
Although clonal deletion is an important central tolerance
mechanism, recent evidence suggests that progenitors canJEM VOL. 202, July 4, 2005 119
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also be positively selected into a regulatory T cell lineage
upon encountering high affinity ligand in the thymus (43,
44). This process has been referred to as “agonist selec-
tion” and applies to three different T cell populations:
CD4 CD25  regulatory T cells, NKT cells, and CD8  
IELs (45). Many questions remain about the factors that lead
to agonist selection. Early work in the field of CD8   IEL
development suggested that this cell type arose extrathymi-
cally. However, recently, it was demonstrated that the ex-
trathymic pathway might only operate under conditions of
lymphopenia, and that the thymus is the primary develop-
mental site for CD8   IELs (18, 19). In addition to where
these cells develop, the progenitor cell giving rise to CD8  
IELs has been controversial. Using TCR transgenic models
for CD8   IEL development, it was suggested that a DN
progenitor gives rise to CD8   IELs, and that in cases
where there are few DP cells (such as in conventional HY
male mice) there are many CD8   IELs (21, 22). Gene pro-
filing studies also showed striking commonalities between
  TCR CD8   IELs and   TCR DN IELs (23, 46). Be-
cause   TCR-expressing cells arise from DN progenitors
and do not develop through a DP intermediate, it was sug-
gested that DN thymocytes are the immediate precursors of
CD8   IELs. Indeed, we found that although CD8   IELs
were present in HYcd4 male mice, there was little agonist
ligand–dependent expansion, suggesting that the large
CD8   IEL population in conventional HY male mice is an
unnatural consequence of the early expression of the recep-
tor at the DN stage. This result was further confirmed using
the HY  transgenic model in which there was no male reac-
tivity in the CD8   IEL population of male mice. In an ele-
gant fate mapping experiment, Eberl et al. demonstrated that
CD8   IELs arose from at least a DN4 stage thymocyte and
likely a DP thymocyte (47). Additionally, Yamagata et al.
were able to generate CD8    cells from in vitro culture of
nonselected HY DP with agonist-expressing stroma in a re-
aggregate culture (48). Our experiments do not preclude DP
thymocytes as intermediates in the generation of CD8  
IELs; however, they do suggest that early TCR expression
(within the DN compartment) is required. It is unclear why
early TCR expression is necessary for the generation of
CD8   IELs, but one could postulate that signals received
by a DN thymocyte from a mature   TCR, as opposed to a
pre-TCR, could in some manner imprint the cell to develop
along this pathway when faced with agonist ligand.
In conclusion, the HYcd4 model has several advantages
over other TCR transgenic and nontransgenic models of de-
velopment, but it also has a few drawbacks. First, it contains
a high frequency of monoclonal cells, which facilitates analy-
sis, but may lead to unnatural effects (as in other TCR trans-
genics). Second, in order to create the HYcd4 mouse, three
transgenes are required. This makes it quite laborious and
time consuming when wanting to introduce other trans-
genes or breed onto a gene-deficient strain. Finally, the level
of TCR expression on mature T cells in these animals is
lower than what is observed in wild-type mice. Although
this issue did not appear to affect the sensitivity of the cells to
ligand, there could be cases in which this would be a prob-
lem. It would be of substantial benefit to engineer a system
where the TCR was expressed at the appropriate time de-
velopmentally, expressed similar amounts of surface TCR to
wild-type mice, and is facile enough to allow the study of
multiple genetic factors.
Overall, the HYcd4 model allowed us to define those
properties of TCR transgenic lymphocyte development that
are nonphysiological and caused by the early expression of
the TCR. Our findings suggest that late (DP to SP) models
of negative selection may be the most appropriate models to
evaluate molecular pathways of clonal deletion, and that im-
proved models are needed to study the development of
CD8   IELs.
MATERIALS AND METHODS
DNA constructs. pCAGGS STOP HY TCR  was generated using stan-
dard molecular biology techniques. In brief, the pEF321 ShcFFF plasmid
containing a floxed transcriptional and translational STOP cassette was ob-
tained from K. Ravichandran (University of Virginia, Charlottesville, VA;
reference 10). The internal ribosomal entry site (IRES)–GFP portion of
pEF321 ShcFFF was replaced with an IRES–GFP cassette provided by S.
Casola (Harvard University, Boston, MA). The HY TCR  cDNA was am-
plified from a cDNA library generated from bulk HY thymocytes and re-
placed the ShcFFF cDNA by directional cloning. The floxed STOP HY
TCR  IRES–GFP fragment was inserted into the pCAGGS vector, gener-
ating pCAGGS STOP HY TCR .
Animals. C57BL/6 (B6), Thy 1 congenic C57BL/6.PL (B6.PL), CD45
congenic C57BL/6.SJL (B6.SJL), and TCR  /  mice were purchased from
the Jackson Laboratory. CD4–Cre and lck–Cre mice were purchased from
Taconic. The conditional HY TCR –expressing mice were generated by
microinjection of the Sal–Not fragment from pCAGGS STOP HY TCR 
into preimplantation C57BL/6 embryos by the Mouse Genetics Laboratory
at the University of Minnesota. Founders were identified by PCR using
primers directed against the 3  region of the STOP cassette. Nine founders
were identified, of which only two appeared to express HY TCR . Data
from founder 8820 are presented. Conventional HY and HY  mice were a
gift of H. von Boehmer (Harvard University, Boston, MA). Mice contain-
ing the HY , CD4–Cre and conditional HY TCR  (HYcd4) or HY , lck–
Cre, and conditional HY TCR  (HYlck) transgenes were obtained by
breeding. All animals were maintained and treated in accordance with fed-
eral guidelines approved by the University of Minnesota Institutional Ani-
mal Care Committee.
Antibodies and flow cytometry. All fluorochrome and biotinylated an-
tibodies were purchased from BD Biosciences, eBioscience, or Biolegend.
Cells were stained with antibody for 30 min on ice in FACS buffer (PBS,
1% FCS, and 0.02% azide, pH 7.2) and washed two times in FACS buffer
after each antibody incubation. Cell events were collected using a cytome-
ter (FACSCalibur or LSRII; BD Biosciences) and analyzed with FlowJo
software (Tree Star Inc.). Db–smcy pentamers were purchased from ProIm-
mune. Pentamer staining was performed in FACS buffer at room tempera-
ture for 30 min before staining with other antibodies.
Purification of IELs. Lymphocytes from the small intestine were purified
using a protocol described by Podd et al. (49). In brief, the small intestine
was isolated, cut longitudinally, and the contents were rinsed out with ice-
cold HBSS. The intestine was then cut into 0.5-cm pieces and incubated
three times at 37 C for 20 min in HBSS and 1 mM dithiothreitol withAN “ON-TIME” TCR TRANSGENIC MODEL | Baldwin et al. 120
shaking. After each round of shaking, the supernatant was strained with a
70- M nylon filter. Cells were pelleted and lymphocytes were enriched by
centrifugation over a 70 /40  Percoll gradient, and the band at the 70 /
40  interface was collected. Cells were washed in RP10 before staining.
In vitro and in vivo stimulation. Responder HY or HYcd4 female thy-
mocytes or bulk LN cells were mixed at a 1:1 ratio with female B6 spleno-
cytes and the indicated concentration of agonist smcy peptide in vitro (50).
Cultures were incubated for 20 h at 37 C and stained with anti-CD4, anti-
CD8, T3.70, and anti-CD69. T3.70  DP or CD8SP cells were electroni-
cally gated, and the expression of CD69 was measured. Data are represented
as the percentages of indicated population that maximally up-regulated
CD69. Bulk thymocytes from HY and HYcd4 female mice were CFSE la-
beled (Molecular Probes) and injected i.v. into unmanipulated male or fe-
male recipients. LNs and spleens were harvested 48 h after injection, stained
with anti-CD4, CD8, CD69, and T3.70, and analyzed on a cytometer
(LSRII; BD Biosciences). Data are presented as the CFSE profile for CD8 
T3.70  cells from the spleen from male or female recipients.
HP. Bulk thymocytes from HY, HYcd4, and B6 female mice were isolated.
HY thymocytes were spiked with B6 thymocytes to provide a reference
population for measurement of HP (HYcd4 mice have a population of
CD8SP that do not express the HY receptor and thus provide a preexisting
internal control). Thymocytes were then CFSE labeled and injected i.v.
into sublethally irradiated congenic B6.SJL mice. LNs and spleens were har-
vested 9 d after injection, and CFSE dilution was measured in the B6, HY,
and HYcd4 CD8 populations.
Online supplemental material. Fig. S1 depicts a quantitative compari-
son of TCR levels in CD69  (positively selected) DP thymocytes from B6,
HY, and HYcd4 mice. Fig. S2 shows a phenotypic and quantitative analysis
of thymocytes (A and B) and IELs (C and D) from HYlck female and male
mice. Fig. S3 depicts a phenotypic analysis of IEL populations (CD8   and
CD8  ) from various mice. Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20050359/DC1.
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